Sign in
CompletedNo phase

MIDAS Cluster Randomized Controlled Trial of Implementation Strategies to Optimize Use of Medications in VA Clinical Settings

Key facts

Who runs it
VA Office of Research and Development
Where
Ann Arbor, United StatesSee the site
Trial code
Status
Completed
People taking part
24 people enrolled
Started
3 May 2021
Ended
14 May 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Academic Detailing (AD)
  • LEAP
Record updated
15 October 2025

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Note- the investigators are recruiting clinics - not individual patients
  • Prior to implementation, the investigators will work with sites to ensure they have met the preconditions necessary to begin sustained optimization of the EBP:; a team leader or champion; an identified department with service leadership buy-in and control over the processes/practices impacted by the implementation; readily accessible data to measure process and impact of the implementation and use of the EBP; availability of required resources

Who cannot take part

  • N/A

Where in United States

  • VA Ann Arbor Healthcare System, Ann Arbor, MIAnn Arbor, United States

About the trial

What the trial wants to find out

Scientific advances are constantly leading to better treatments. However, it is quite challenging for healthcare systems, including VA, to ask very busy providers to change the way they practice. The MIDAS QUERI program will help providers improve the way they treat VA patients for three common conditions, using specific strategies to ensure the reliable delivery of these treatments. The first project will focus on reducing potentially inappropriate medication (PIM) use using the VIONE practice, developed in VA. The second project will focus on better use of drugs called direct oral anticoagulants (DOACs) for patients with a history of severe blood clots or an abnormal heart rhythm. The third project will focus on increasing the use of cognitive behavioral therapy for insomnia as the first-line treatment for insomnia instead of sleep medications. The investigators will test two implementation approaches to improve medication use within these topics.

The 2 groups in the trial

  • Academic Detailing (AD) OnlyExisting treatment, for comparison

    One-on-one educational outreach to employees and providers.

    Treatment: Academic Detailing (AD)

  • AD + LEAP CombinedTreatment being tested

    This arm combines use of AD plus the Learn. Engage. Act. Process (LEAP) program. LEAP is a 6-month quality improvement coaching program plus a 6-month monthly follow-up.

    Treatment: Academic Detailing (AD) and LEAP

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Maintaining Implementation Through Dynamic Adaptations (MIDAS) (QUE 20-025)
Publications
Record updated
15 October 2025